OncoSil Medical Limited is an Australian-based medical device company that develops and commercializes medical products to treat pancreatic and liver cancer. The Company's trademark product, OncoSil, is an active implantable brachytherapy device which treats cancer by implanting radioactive microparticles directly into the cancerous tumour.

OSPREY Analysis Shows Survival Benefit for OncoSil Patients

Change of Director's Interest Notice x3

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Oncosil Medical (OSL AU)

OSPREY Analysis Shows Survival Benefit for OncoSil Patients

Change of Director's Interest Notice x3

Notification regarding unquoted securities - OSL

Application for quotation of securities - OSL

Final Director's Interest Notice

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)